FedEx Express, a subsidiary of FedEx Corp, announced its seventh edition of ‘SME Connect’ on ‘Emerging Possibilities for SMEs in Pharma, Healthcare, and Life Science’. The virtual ‘SME Connect’ series is a thought leadership and knowledge-sharing platform. Small and medium enterprises (SMEs) can access greater opportunities by interacting with industry thought leaders and subject matter experts for solution-oriented discussions that benefit their business.  

This edition of the FedEx SME Connect series focuses on industry leaders sharing business insights on pharma and healthcare trends, opportunities, and challenges. The session highlights the impact of disruptive technologies and automation on SMEs in the healthcare sector, key government policies fuelling industry growth, and how SMEs can ride the wave of global demand and opportunities, with exports sustaining a positive growth momentum despite global trade disruptions.

“The COVID-19 pandemic called for a complete revolution of the pharma supply chain. As pharmaceutical demand continues to show an upward trend, a reliable and more efficient supply chain will play a bigger role for SMEs in India. The FedEx SME Connect series enables Indian SMEs to expand into new and existing markets globally and in India through engaging insights and solutions, equipping them for what’s next,” said Salil Chari, Senior VP, Marketing and Customer Experience, AMEA.